Fingerprint
Dive into the research topics of 'Phase II study of erlotinib in patients with malignant pleural mesothelioma: A Southwest Oncology Group study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of erlotinib in patients with malignant pleural mesothelioma: A Southwest Oncology Group study
Linda L. Garland, Cathryn Rankin, David R Gandara, Saul E. Rivkin, Katherine M. Scott, Raymond B. Nagle, Andres J P Klein-Szanto, Joseph R. Testa, Deborah A. Altomare, Ernest C. Borden
Research output: Contribution to journal › Article › peer-review
185
Scopus
citations